-
-
-
-
-
-
-
Sierra Oncology (SRRA) Acquired by GlaxoSmithKline (GSK) for $55/sh or $1.9B
-
-
-
-
-
-
-
Sierra Oncology (SRRA) Announces Baseline Ferritin Differentially Predicts Week 24 Transfusion Independence Response in Myelofibrosis Patients
-
-
-
-
-
-
-
Sierra Oncology Announces Momelotinib Poster Accepted for Presentation at ASH
-
-
-
-
-
-
-
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Sierra Oncology Announces Abstracts Accepted for American Society of Clinical Oncology Annual Meeting
-
-
-
-
-
-
-
Sierra Oncology Announces Presentation at LifeSci Partners Precision Oncology Day
-
-
-
-
-
-
-
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
-
1,154,893 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

